Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

KPTIKPTI
6 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in KARYOPHARM THERAPEUTICS INC

Yes. Adage Capital Partners GP holds 1,521,322 shares of KPTI (Karyopharm Therapeutics), worth $14.9M, as of its Q2 2026 13F filing. It reduced the position by 285,000 shares (-15.8%) from Q1 2026. Adage Capital Partners GP has held KPTI in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$14.9M

Current Shares

1.5M

Total Value Change

+$13.3M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-15.8%
$14.9M0.0%$9.77
0
2026-Q1
Increased
1.8M
+328.7%
$10.1M0.0%$5.57
45
2025-Q4
Unchanged
421,322
0.0%
$3.1M0.0%$7.36
0
2025-Q3
Unchanged
421,322
0.0%
$2.8M0.0%$6.54
0
2025-Q2
Unchanged
421,322
0.0%
$1.8M0.0%$4.31
0
2025-Q1
New
421,322
-
$1.6M0.0%$3.74
35

Other major holders of KPTI: RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used